National Academies Press: OpenBook

Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines (2022)

Chapter: Appendix C: Agendas: Open Committee Meetings

« Previous: Appendix B: Biographical Sketches of Committee Members and Staff
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 231
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 232
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 233
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 234
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 235
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 236
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 237
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 238
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 239
Suggested Citation:"Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
×
Page 240

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix C Agendas: Open Committee Meetings This appendix presents the agendas for the open portions of the committee’s meetings, at which a wide range of experts provided invaluable input to the committee’s deliberations. Committee on Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response March Meeting March 11, 2021: 12:00 pm ET – 1:30 pm ET March 12, 2021: 11:00 am ET – 12:30 pm ET March 17, 2021: 10:45 am – 1:15 pm ET March 19, 2021: 11:00 am – 12:15 pm ET Location: Virtual Meeting Objectives • Conduct committee and staff introductions • Conduct the bias and conflict of interest discussion • Orient the committee to the consensus study process • Hear from the sponsoring agency on their perspective of the statement of task • Discuss the statement of task and the study’s approach • Hear from speakers to better understand the unmet needs in vaccine manu- facturing and distribution • Identify information needs and future meeting topics 231

232 GLOBALLY RESILIENT SUPPLY CHAINS Wednesday, March 17, 2021 OPEN SESSION SESSION II SPONSOR BRIEFING: DISCUSSION OF THE COMMITTEE’S CHARGE 10:45 a.m. Welcome and Introductions Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair President’s Advisory Committee on Labor Standards and Human Rights University of Michigan 10:55 a.m. Sponsor Perspective on Charge to the Committee Lawrence Kerr, Sponsor Office of Pandemic and Emerging Threats Office of Global Affairs U.S. Department of Health and Human Services 11:10 a.m. Q&A Discussion with Committee 11:25 a.m. BREAK SESSION III PANDEMIC INFLUENZA AND NEW PATHOGEN VACCINE DISTRIBUTION 11:35 a.m. Needs in Influenza and New Pathogen Vaccine Distribution Lisa Hedman Group Lead, Supply and Access to Medicines World Health Organization Nagwa Hasanin Senior Advisor, Health UNICEF Stacey Knobler Director, Influenza Vaccine Innovation Sabin Vaccine Institute

APPENDIX C 233 Session Moderator Pinar Keskinocak William W. George Professor and Chair School of Industrial and Systems Engineering Georgia Institute of Technology 1:00 p.m. Q&A Discussion with Committee 1:15 p.m. ADJOURN Friday, March 19, 2021 OPEN SESSION SESSION IV NEEDS IN INFLUENZA VACCINE MANUFACTURING PREPAREDNESS 11:00 a.m. Welcome and Recap of Day 1 11:10 a.m. Needs in Influenza Vaccine Manufacturing Preparedness Rick Bright Senior Vice-President, Pandemic Preparedness The Rockefeller Foundation Matthew Downham Sustainable Manufacturing Lead Coalition for Epidemic Preparedness Innovations (CEPI) Tiago Rocca Strategic Partnerships and Business Development Manager Butantan Institute Session Moderator Jennifer Pancorbo Director, Industry Programs and Research North Carolina State University Biomanufacturing Training and Education Center 11:55 a.m. Q&A Discussion with Committee

234 GLOBALLY RESILIENT SUPPLY CHAINS 12:15 p.m. ADJOURN OPEN SESSION April Meeting April 23, 2021: 9:30 am ET – 12:00 pm ET April 27, 2021: 11:30 am ET – 12:30 pm ET April 30, 2021: Closed Session for Committee Members Only Location: Virtual Meeting Objectives • Hear varying perspectives on the critical inputs necessary for pandemic and seasonal influenza vaccine manufacturing • Learn about the feasibility, scale-up, and adaptability of vaccine technologies for multiple products • Better understand vaccine information systems and considerations for equi- table vaccine distribution • Identify information needed to draw conclusions and make recommendations Friday, April 23, 2021 OPEN SESSION 9:30 a.m. Welcome Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair President’s Advisory Committee on Labor Standards and Human Rights University of Michigan SESSION I CRITICAL INPUTS FOR VACCINE MANUFACTURING Speakers will share their perspective on the critical inputs necessary for vaccine manufacturing. 9:35 a.m. Robert Johnson Director, Influenza and Emerging Infectious Diseases Division Biomedical Advanced Research and Development Authority

APPENDIX C 235 Michael Angelastro Lead Interdisciplinary Scientist Biomedical Advanced Research and Development Authority 9:50 a.m. Q&A Discussion with Committee 10:05 a.m. Sai Prasad President of Quality Operations, Bharat Biotech International Ltd. 10:20 a.m. Q&A Discussion with Committee 10:35 a.m. William Jay Treat Chief Manufacturing Officer and Principal Investigator Center for Innovation in Advanced Development & Manufacturing Texas A&M University 10:50 a.m. Q&A Discussion with Committee Moderator Matthew Downham Sustainable Manufacturing Lead Coalition for Epidemic Preparedness Innovations 11:05 a.m. BREAK SESSION II NOVEL TECHNOLOGIES FOR INFLUENZA VACCINE MANUFACTURING Speakers will discuss how novel technologies and advances in translational research and science, derived from the ongoing COVID-19 pandemic, have the potential to be adapted to scale-up and sustain influenza vaccine manufacturing capacities. 11:10 a.m. Technology Scale-Up and Adaptability Lyn Morgan Senior Director Global Public Affairs, Vaccines Sanofi Pasteur Suresh Jadhav Executive Director Serum Institute of India

236 GLOBALLY RESILIENT SUPPLY CHAINS Patrick Tippoo Head of Science and Innovation Biovac Institute Moderator Rick Bright Senior Vice-President, Pandemic Preparedness The Rockefeller Foundation 11:40 a.m. Q&A Discussion with Committee 12:00 p.m. ADJOURN Tuesday, April 27, 2021 OPEN SESSION 11:30 a.m. Welcome and Recap of Day 1 Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair, President’s Advisory Committee on Labor Standards and Human Rights University of Michigan 11:35 a.m. Key Considerations for Vaccine Distribution Pinar Keskinocak William W. George Professor and Chair School of Industrial and Systems Engineering Georgia Institute of Technology 11:50 a.m. Q&A Discussion with Committee 12:00 p.m. Vaccine Information Systems: Improvements Needed to Support Influenza Skye Gilbert Executive Director, Digital Square PATH

APPENDIX C 237 12:15 p.m. Q&A Discussion with Committee Moderator Prashant Yadav, Committee Vice Chair Senior Fellow, Center for Global Development Professor, INSEAD Lecturer, Harvard Medical School 12:30 p.m. ADJOURN OPEN SESSION May Meeting May 21, 2021: 11:25 am ET – 1:30 pm ET Location: Virtual Meeting Objectives • Better understand logistical and on-the-ground needs for vaccine distribution • Understand the triggers to release product stockpiles and overall stockpile management • Hear about processes to help speed cross-border approval and distribution for vaccines • Better understand the World Health Organization’s (WHO’s) training programs for manufacturers and regulators, as well as efforts to scale up vaccine manu- facturing through mRNA hubs Friday, May 21, 2021 OPEN SESSION 11:25 a.m. Welcome & Recap of Day 2 Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair President’s Advisory Committee on Labor Standards and Human Rights University of Michigan 11:30 a.m. Cross-Border Processes and Approval for Vaccines and Vaccine Supplies Roy Santana Counsellor Market Access Division World Trade Organization

238 GLOBALLY RESILIENT SUPPLY CHAINS Michael Roberts Head, Aid for Trade Unit Development Division World Trade Organization Roger Kampf Counsellor Intellectual Property Division World Trade Organization 11:45 a.m. Q&A Discussion with Committee Moderator Matthew Downham Sustainable Manufacturing Lead Coalition for Epidemic Preparedness Innovations 12:00 p.m. Pandemic Influenza Vaccine Distribution: The PIVI Model Joseph Bresee Associate Director of Global Health Affairs, Influenza Division National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Director, Partnership for Influenza Vaccine Introduction Task Force for Global Health Director, Global Funders Consortium for Universal Influenza Vaccine Development 12:15 p.m. Q&A Discussion with Committee Moderator Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair, President’s Advisory Committee on Labor Standards and Human Rights University of Michigan

APPENDIX C 239 12:30 p.m. WHO Training Programs and mRNA Hubs Martin Friede Coordinator Initiative for Vaccine Research World Health Organization 12:45 p.m. Q&A Discussion with Committee Moderator Jennifer Pancorbo Director, Industry Programs and Research Biomanufacturing Training and Education Center North Carolina State University 1:00 p.m. Navigating Vaccine Logistics in Africa Ahmed Ogwell Ouma Deputy Director Africa Centres for Disease Control and Prevention 1:15 p.m. Q&A Discussion with Committee Moderator Ravi Anupindi, Committee Chair Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair, President’s Advisory Committee on Labor Standards and Human Rights University of Michigan 1:30 p.m. ADJOURN OPEN SESSION

Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines Get This Book
×
Buy Paperback | $62.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Influenza viruses, both seasonal and pandemic, have the potential to disrupt the health and well-being of populations around the world. The global response to the COVID-19 pandemic and prior public health emergencies of international concern illustrate the importance of global preparedness and coordination among governments, academia, scientists, policy makers, nongovernmental organizations, the private sector, and the public to address the threat of pandemic influenza. These health emergencies have revealed opportunities to enhance global vaccine infrastructure, manufacturing, distribution, and administration.

Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines outlines key findings and recommendations to bolster vaccine distribution, manufacturing, and supply chains for future seasonal and pandemic influenza events. This report addresses the challenges of manufacturing and distributing vaccines for both seasonal and pandemic influenza, highlighting the critical components of vaccine manufacturing and distribution and offering recommendations that would address gaps in the current global vaccine infrastructure.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!